Published: 2020-02-24

A study on efficacy of injection of intratympanic dexamethasone in treatment of sudden sensorineural hearing loss

Srirangaprasad K., Vinay Kumar V., Pruthvi Raj S.


Background: Sudden sensorineural hearing loss is a common otologic emergency which occurs due to various etiologies affecting the inner ear. Majority of treatment protocols are focussed on glucocorticoids either systemically or through intratympanic route due to their antioxidant and anti-inflammatory properties.

Methods: This was a pre and post observational clinical study conducted in patients visiting Rajarajeswari medical college between December 2015 to December 2016 with a history of sudden hearing loss (30 patients). 6 of these patients presented with bilateral hearing loss, and we considered each ear as a separate case, giving us a total of 36 cases. A diagnosis of idiopathic sudden sensorineural hearing loss was made based on the patient’s history and audiological evaluation. All the patients were treated with 3 doses of Intratympanic injections of Dexamethasone (4 mg/ml), on alternate days. Pure tone audiometry (PTA) and brain stem evoked response audiometry (BERA) was done pre-treatment, at 1 and 6 months after treatment.  

Results: Mean age of our patients was 44.8. 80% of our patients were male. The average PTA gain, 1 month after treatment was 27.917 and 6 months after treatment was 29.639 with a p value of <0.001, which correlated with BERA. At the end of 6 months after treatment, 15 cases had complete recovery (41.7%), 9 cases showed slight recovery (25%), 6 cases had marked recovery and 6 cases (16.7%) had no recovery.

Conclusions: Intratympanic dexamethasone injections can be used as the first line of treatment with minimal side effects. 


Intratympanic injection, Dexamethasone, Sudden sensorineural hearing loss

Full Text:



Hughes GB, Freedman MA, Haberkamp TJ, Guay ME. Sudden sensorineural hearing loss. Otolaryngol Clin North Am. 1996;29(3):393-405.

Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol. 1980;106(12):772-6.

Furuhashi A, Matsuda K, Asahi K, Nakashima T. Sudden deafness: long-term follow-up and recurrence. Clin Otolaryngol. 2002;27:458-63.

Megighian D, Bolzan M, Barion U, Nicolai P. Epidemological considerations in sudden hearing loss: a study of 183 cases. Arch Otorhinolaryngol. 1986;243(4):250-3.

Oh J, Park K, Lee S, Shin Y, Choung Y. Bilateral versus unilateral sudden sensorineural hearing loss. Otolaryngol - Head Neck Surg. 2007;136(1):87-91.

Rauch S. Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss. JAMA. 2011;305(20):2071.

Tsai HT, Hsueh N, Huang CM, Lin HC. Intratympanic steroid injection as a first-line therapy in uremia patients with sudden sensorineural hearing loss. 14 Acta Otolaryngol. 2015;135(8):786-90.

Van der Drift J, Brocaar M, Van Zanten G. The Relation between the Pure-Tone Audiogram and the Click Auditory Brainstem Response Threshold in Cochlear Hearing Loss: Int J Audiol. 1987;26(1):1-10.

Dhingra PL, Dhingra S, Dhingra D. Diseases of Ear, Nose and Throat & Head and Neck Surgery, 6/e, Elsevier, India; 2014: 3-4.